KWMG
King Wealth Management Group’s Theravance Biopharma TBPH Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-45,000
| Closed | -$408K | – | 164 |
|
2022
Q2 | $408K | Sell |
45,000
-77,000
| -63% | -$698K | 0.1% | 94 |
|
2022
Q1 | $1.17M | Buy |
122,000
+109,000
| +838% | +$1.04M | 0.23% | 58 |
|
2021
Q4 | $144K | Hold |
13,000
| – | – | 0.03% | 170 |
|
2021
Q3 | $96K | Sell |
13,000
-10,000
| -43% | -$73.8K | 0.02% | 168 |
|
2021
Q2 | $334K | Hold |
23,000
| – | – | 0.07% | 131 |
|
2021
Q1 | $469K | Hold |
23,000
| – | – | 0.11% | 98 |
|
2020
Q4 | $409K | Hold |
23,000
| – | – | 0.1% | 108 |
|
2020
Q3 | $340K | Hold |
23,000
| – | – | 0.09% | 111 |
|
2020
Q2 | $483K | Buy |
23,000
+8,200
| +55% | +$172K | 0.14% | 82 |
|
2020
Q1 | $342K | Sell |
14,800
-7,700
| -34% | -$178K | 0.15% | 85 |
|
2019
Q4 | $583K | Buy |
22,500
+5,000
| +29% | +$130K | 0.15% | 62 |
|
2019
Q3 | $341K | Sell |
17,500
-7,000
| -29% | -$136K | 0.1% | 90 |
|
2019
Q2 | $400K | Buy |
24,500
+7,500
| +44% | +$122K | 0.12% | 81 |
|
2019
Q1 | $385K | Buy |
+17,000
| New | +$385K | 0.12% | 81 |
|